SCHEMBL7908310

SCHEMBL7908310

CCC(N)(CC)c1ccc(F)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 3/20 0.40
CYP17A1 P05093 1/20 0.38
LOXL2 Q9Y4K0 1/20 0.37
ACHE P22303 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.35
ALDH1A1 P00352 1/20 0.35
TAAR1 Q96RJ0 1/20 0.34
RAB9A P51151 2/20 0.34
USP2 O75604 1/20 0.34
LMNA P02545 1/20 0.34
KDM4E B2RXH2 1/20 0.34
RIPK1 Q13546 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
AOC3 Q16853 1/20 0.33
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20273007 0.87 ESR1 (0.40) KCNN4RAB9AMEN1NPC1MAPT
SCHEMBL3988420 0.81 TAAR1 (0.45) ALDH1A1TAAR1LMNACYP3A4CYP2C19
SCHEMBL7905302 0.79 KCNN4 (0.39) KCNN4CYP17A1LOXL2ACHESMN1; SMN2
SCHEMBL3161216 0.78 MAPT (0.48) LOXL2ACHEALDH1A1RAB9ACYP3A4
SCHEMBL13756441 0.78 TSHR (0.46) ACHETAAR1RAB9AMEN1NPC1
SCHEMBL24041245 0.76 ESR1 (0.33) RAB9AMEN1NPC1MAPTKMT2A
SCHEMBL13749516 0.76 CYP19A1 (0.46) SMN1; SMN2ALDH1A1LMNAKDM4EMEN1
SCHEMBL24855930 0.76 CYP2A6 (0.38) ALDH1A1TAAR1MEN1MAPK1KMT2A
SCHEMBL2568927 0.76 KCNN4 (0.45) KCNN4LOXL2TAAR1RAB9AUSP2
SCHEMBL9550959 0.76 ESR1 (0.60) ACHESMN1; SMN2ALDH1A1USP2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6200993-B1 ASTHMA; ANTIINFLAMMATORY AGENTS MERCK FROSST CANADA & CO. (CA) 2001-03-13 US disclosed